The new inhibitor of monoamine oxidase, M30, has a neuroprotective effect against dexamethasone-induced brain cell apoptosis
Stress detrimentally affects the brain and body and can lead to or be accompanied by depression. Although stress and depression may contribute to each other, the exact molecular mechanism underlying the effects is unclear. However, there is a correlation between stress and an increase in glucocorti...
Main Authors: | Shakevia Johnson, Xiao-Ming Ou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2010-11-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2010.00180/full |
Similar Items
-
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
by: Kok Pin Ng, et al.
Published: (2017-03-01) -
Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways
by: Saba Feizipour, et al.
Published: (2020-05-01) -
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
by: Rona R. Ramsay, et al.
Published: (2017-07-01) -
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
by: John Paul Maurice Finberg, et al.
Published: (2016-10-01) -
Neuroprotective Effects of Metformin Versus Selegiline on Parkinson’s Disease Model By Reserpine through the Interrelation of α Synuclein and Antioxidants on Behavioral Changes in Rats
by: Ghada Farouk Soliman, et al.
Published: (2019-11-01)